These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20087783)

  • 1. Hepatocellular carcinomas in cirrhotic and noncirrhotic human livers share angiogenic characteristics.
    Zeng W; Gouw AS; van den Heuvel MC; Molema G; Poppema S; van der Jagt EJ; de Jong KP
    Ann Surg Oncol; 2010 Jun; 17(6):1564-71. PubMed ID: 20087783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
    El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N
    Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.
    Yang LY; Lu WQ; Huang GW; Wang W
    BMC Cancer; 2006 May; 6():110. PubMed ID: 16650286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry.
    Kimura H; Nakajima T; Kagawa K; Deguchi T; Kakusui M; Katagishi T; Okanoue T; Kashima K; Ashihara T
    Liver; 1998 Feb; 18(1):14-9. PubMed ID: 9548262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis and proliferation markers in adjacent cirrhotic tissue could predict hepatocellular carcinoma outcome after liver transplantation.
    Campillo A; Solanas E; Morandeira MJ; Castiella T; Lorente S; Garcia-Gil FA; Piazuelo E; de Martino A; Serrano MT
    Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):871-9. PubMed ID: 24922356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of vasohibin 1-associated angiogenesis in patients with hepatocellular carcinoma.
    Murakami K; Kasajima A; Kawagishi N; Sekiguchi S; Fujishima F; Watanabe M; Sato Y; Ohuchi N; Sasano H
    Hum Pathol; 2014 Mar; 45(3):589-97. PubMed ID: 24444468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
    Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
    Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facing the enigma of the vascular network in hepatocellular carcinomas in cirrhotic and non-cirrhotic livers.
    Vasuri F; Fittipaldi S; Giunchi F; Monica M; Ravaioli M; Degiovanni A; Bonora S; Golfieri R; Bolondi L; Grigioni WF; Pasquinelli G; D'Errico-Grigioni A
    J Clin Pathol; 2016 Feb; 69(2):102-8. PubMed ID: 26243063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-level dynamic spiral CT of hepatocellular carcinoma: correlation between imaging features and density of tumor microvessels.
    Chen WX; Min PQ; Song B; Xiao BL; Liu Y; Ge YH
    World J Gastroenterol; 2004 Jan; 10(1):67-72. PubMed ID: 14695771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical characteristics of hepatocellular carcinoma in non-cirrhotic livers.
    Witjes CD; ten Kate FJ; Verhoef C; de Man RA; IJzermans JN
    J Clin Pathol; 2013 Aug; 66(8):687-91. PubMed ID: 23585667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlative study of angiogenesis and dynamic contrast-enhanced magnetic resonance imaging features of hepatocellular carcinoma.
    Wang B; Gao ZQ; Yan X
    Acta Radiol; 2005 Jul; 46(4):353-8. PubMed ID: 16134309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of microRNA-16, microRNA-21 and microRNA-101 expression with cyclooxygenase-2 expression and angiogenic factors in cirrhotic and noncirrhotic human hepatocellular carcinoma.
    Zeng W; van den Berg A; Huitema S; Gouw AS; Molema G; de Jong KP
    PLoS One; 2014; 9(4):e95826. PubMed ID: 24759835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression.
    Paschoal JP; Bernardo V; Canedo NH; Ribeiro OD; Caroli-Bottino A; Pannain VL
    BMC Cancer; 2014 Feb; 14():72. PubMed ID: 24507660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancer.
    Wang WQ; Liu L; Xu HX; Luo GP; Chen T; Wu CT; Xu YF; Xu J; Liu C; Zhang B; Long J; Tang ZY; Yu XJ
    PLoS One; 2013; 8(8):e71189. PubMed ID: 23940715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MSCT perfusion imaging and its correlation with perfusion parameters, survivin expression, MVD, and pathologic grade in hepatocellular carcinomas].
    Long X; Cao J; Shi L; Li W; Liu H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 34(11):1096-102. PubMed ID: 19952399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features.
    Ribeiro OD; Canedo NH; Pannain VL
    Clinics (Sao Paulo); 2016 Nov; 71(11):639-643. PubMed ID: 27982164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvessel density of hepatocellular carcinoma: its relationship with prognosis.
    Sun HC; Tang ZY; Li XM; Zhou YN; Sun BR; Ma ZC
    J Cancer Res Clin Oncol; 1999 Jul; 125(7):419-26. PubMed ID: 10394963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study.
    Poon RT; Ng IO; Lau C; Yu WC; Yang ZF; Fan ST; Wong J
    J Clin Oncol; 2002 Apr; 20(7):1775-85. PubMed ID: 11919234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential prognostic value of leptin receptor in hepatocellular carcinoma.
    Wang SN; Chuang SC; Yeh YT; Yang SF; Chai CY; Chen WT; Kuo KK; Chen JS; Lee KT
    J Clin Pathol; 2006 Dec; 59(12):1267-71. PubMed ID: 16565226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of caveolin in hepatocellular carcinoma: association with unpaired artery formation and radiologic findings].
    Choi HN; Kim KR; Park HS; Jang KY; Kang MJ; Lee DG; Kim YK; Cho BH; Cha EJ; Moon WS
    Korean J Hepatol; 2007 Sep; 13(3):396-408. PubMed ID: 17898556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.